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Abstract
AIM
To investigate the additional clinical impact of hepatic 
ischaemia reperfusion injury (HIRI) on patients sustaining 
acute kidney injury (AKI) following liver transplantation.
METHODS
This was a single-centre retrospective study of consecutive 
adult patients undergoing orthotopic liver transplantation 
(OLT) between January 2013 and June 2014. Early AKI 
was identified by measuring serum creatinine at 24 h 
post OLT (> 1.5 × baseline) or by the use of continuous 
veno-venous haemofiltration (CVVHF) during the early 
post-operative period. Patients with and without AKI 
were compared to identify risk factors associated with 
this complication. Peak serum aspartate aminotransferase 
(AST) within 24 h post-OLT was used as a surrogate 
marker for HIRI and severity was classified as minor (< 
1000 IU/L), moderate (1000-5000 IU/L) or severe (> 
5000 IU/L). The impact on time to extubation, intensive 
care length of stay, incidence of chronic renal failure 
and 90-d mortality were examined firstly for each of the 
two complications (AKI and HIRI) alone and then as a 
combined outcome. 
RESULTS
Out of the 116 patients included in the study, 50% deve-
loped AKI, 24% required CVVHF and 70% sustained 
Submit a Manuscript: http://www.f6publishing.com
DOI: 10.4254/wjh.v9.i18.823
World J Hepatol  2017  June 28; 9(18): 823-832
ISSN 1948-5182 (online)
824 June 28, 2017|Volume 9|Issue 18|WJH|www.wjgnet.com
Rahman S et al . Early AKI after liver transplantation
moderate or severe HIRI. Median peak AST levels 
were 1248 IU/L and 2059 IU/L in the No AKI and AKI 
groups respectively (P  = 0.0003). Furthermore, peak 
serum AST was the only consistent predictor of AKI 
on multivariate analysis P  = 0.02. AKI and HIRI were 
individually associated with a longer time to extubation, 
increased length of intensive care unit stay and reduced 
survival. However, the patients who sustained both AKI 
and moderate or severe HIRI had a longer median time 
to extubation (P  < 0.001) and intensive care length 
of stay (P = 0.001) than those with either complication 
alone. Ninety-day survival in the group sustaining both 
AKI and moderate or severe HIRI was 89%, compared to 
100% in the groups with either or neither complication (P  
= 0.049). 
CONCLUSION
HIRI has an important role in the development of AKI 
post-OLT and has a negative impact on patient outcomes, 
especially when occurring alongside AKI. 
Key words: Hepatic ischaemia reperfusion injury; Liver 
transplantation; Perioperative care; Acute kidney injury; 
Marginal grafts
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Core tip: Acute kidney injury (AKI) is common after liver 
transplantation (LT), and has a significant impact on 
patient outcomes. It is multifactorial in aetiology and 
has been shown to correlate with the use of higher risk 
grafts, due to an increased risk of hepatic ischaemia 
reperfusion injury. In context of the growing use of 
marginal grafts to meet demands, this study has demon-
strated that hepatic ischaemia reperfusion injury was 
the only variable that predicted early AKI post-LT and 
that the presence of both HIRI and AKI led to worse 
clinical outcomes and higher mortality than either com-
plication alone.
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INTRODUCTION
Acute kidney injury (AKI) developing immediately after 
orthotopic liver transplantation (OLT) is common, and 
is associated with increased morbidity, mortality and 
resource utilisation[1]. It affects between 25% and 60% 
of recipients[2-4], the variation being largely related to 
the definition of AKI utilised[5,6]. The incidence of AKI 
following OLT is much higher than with other non-cardiac 
major surgery, in patients with previously normal renal 
function[7]. This reflects the additional risks facing the liver 
transplant recipient during the intra and post-operative 
course. 
Multiple factors predisposing liver transplant patients to 
post operative AKI have been identified. Pre-operatively, 
existing renal impairment, increasing Model for End stage 
Liver Disease Score, diabetes mellitus, hypertension[4] 
and obesity have all been associated with post OLT renal 
dysfunction. Intraoperative mean arterial pressure, vaso-
pressor requirements, blood loss and transfusion of blood 
products are additional risk factors[8,9]. Post-operatively, 
graft dysfunction and immunosuppression therapy have 
been regarded as the main renal insults.
More recently, the growing demand for organs in 
LT has led to the use of increasingly higher risk grafts, 
in order to reduce the waiting list mortality[10-12]. These 
include grafts from older donors, prolonged preservation 
period, graft steatosis, split or partial liver allografts 
and donation after cardiac death (DCD). In the United 
Kingdom, DCD organs in particular have been increasingly 
used over the last decade, accounting for 20% of all 
liver transplants in 2014/15 (compared to 17% in 2012 
and 5% in 2005)[13-15]. This group have been shown to 
be at a higher risk of both hepatic and extra-hepatic 
complications, including AKI, which is the most common 
complication encountered following the transplantation of 
marginal grafts. The post-operative systemic inflammatory 
response that occurs as a result of the hepatic ischaemia 
reperfusion injury (HIRI) following warm ischaemia at 
retrieval is thought to play a critical role in the pathogenesis 
of renal injury in these patients[16]. In keeping with this, 
peak peri-operative serum aspartate aminotransferase 
(AST), which is a surrogate marker for HIRI[17,18], has 
been found to be a significant variable related to renal 
outcomes[19-21]. 
The additional impact of HIRI on early post-operative 
renal dysfunction of liver transplant recipients has not 
been widely investigated. Previous studies, especially 
those based on large national databases do not usually 
have sufficient clinical information to analyse the pre-
disposing factors. Early identification of those at risk, 
followed by prevention and management of HIRI may 
have important implications on the outcomes of these 
patients.
The aims of this study were firstly to identify the 
incidence, risk factors and clinical outcomes of early AKI 
in our cohort of patients, and secondly to investigate 
the incidence of HIRI, its correlation with AKI and its 
additional impact on patient outcomes.
MATERIALS AND METHODS
Single-centre retrospective observational study of con-
secutive adults (≥ 18 years of age) undergoing OLT 
between January 2013 and June 2014 at the Royal Free 
London NHS Foundation Trust, one of the 8 Liver Transplant 
centres in the United Kingdom and Ireland. Exclusion 
criteria were those requiring urgent transplantation for 
acute liver failure and those receiving a combined liver-
kidney transplant. 
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To analyse possible factors associated with post OLT 
AKI we included recipient age, gender, weight, aetiology 
of liver disease, Model for End-Stage Liver Disease (MELD) 
score, presence of anaemia (haemoglobin) and the pre-
sence of diabetes mellitus, hypertension and pre-existing 
renal dysfunction [serum creatinine > 100 μmol/L on the 
day of admission prior to OLT (baseline)]. Donor data 
was taken from a prospectively compiled database and 
included donor age, donor status [DCD or donation after 
brain death (DBD)] and cold ischaemic time.
Intraoperative factors assessed included surgical 
technique (piggy back or caval replacement), blood pro-
ducts transfused during OLT (packed red cell units, fresh 
frozen plasma and platelets), transfused cell salvage 
blood (as a reflection of blood loss) and noradrenaline 
infusion rate on admission to intensive care (as a reflection 
of possible ischaemia reperfusion injury). 
Post-operative AKI was determined from serum creat-
inine at midnight on Day 1 and the need for continuous 
veno-venous haemofiltration (CVVHF) during the post-
operative stay on intensive care unit (ICU). Peak serum 
AST within the first 24 h post-OLT was used as a measure 
of ischaemia reperfusion injury. 
Clinical outcomes measured aside from the presence 
of AKI included time to extubation, intensive care length 
of stay, the incidence of chronic renal failure (CRF), as 
demonstrated by an estimated glomerular filtration rate 
of < 60 mL/min per 1.73 m2 at 6 mo post transplantation 
and 90-d patient survival.
Extent of AKI was assessed using the AKIN criteria[22], 
with the multiple rise in creatinine at 24 h post OLT 
compared to baseline, categorising the post-operative 
renal status into: No AKI (< 1.5-fold rise in creatinine); 
Stage 1 (1.5-2 fold rise); Stage 2 (2-3 fold rise) and 
Stage 3 (> 3 fold rise or the commencement of renal 
replacement therapy). This time frame was chosen to 
ensure that the renal complication was not due to post-
operative factors such as nephrotoxicity secondary to 
immunosuppression. 
The incidence of AKI at 24 h post OLT was determined 
and patients with no AKI vs those with any grade of 
AKI were compared in terms of baseline recipient chara-
cteristics, donor graft characteristics and intraoperative 
variables. The two groups were then compared with respect 
to time taken until extubation, intensive care length of stay 
(ICU LOS), incidence of CRF and 90 d patient survival. Risk 
factors for early AKI were then determined including the 
variables outlined above. 
Incidence and severity of HIRI were determined using 
peak serum AST within 24 h of OLT, putting recipients 
into the groups: Mild HIRI (AST < 1000 IU/L); moderate 
HIRI (AST 1000-5000 IU/L) and severe HIRI (AST > 
5000 IU/L). These groups were compared in terms of 
time taken until extubation, ICU LOS, incidence of CRF 
and 90 d patient survival. Peak AST levels within 24 h 
post OLT were correlated with the presence of early AKI 
and organ status. 
Clinical outcomes (time taken until extubation, ICU 
LOS, CRF and 90 d patient survival) were then compared 
between those with neither AKI nor HIRI, either com-
plication or both AKI and HIRI. In this context, HIRI was 
identified as those with moderate or severe HIRI. 
Statistical analysis 
Continuous parametric variables were expressed as 
means with SDs, and compared using student’s t test and 
ANOVA analysis of variance. Continuous non-parametric 
variables were expressed as medians with interquartile 
ranges, and compared using the Mann Whitney U test 
and Kruskal Wallis analysis of variance. Normality of 
data was confirmed using both Shapiro Wilk test and 
histogram analysis. Categorical variables were analysed 
using χ 2 test or Fisher’s exact test and correlations 
between variables were analysed using Spearman’
s or Pearson’s rank correlation for non-parametric and 
parametric data respectively. Kaplan Meier plots were 
used to analyse survival with log rank tests for differences 
and logistic regression analysis was performed to identify 
variables associated with AKI. A P value of < 0.05 was 
considered statistically significant unless otherwise 
stated. Statistical analysis was carried out using Microsoft 
Excel and IBM SPSS Statistics Version 24.
RESULTS
One hundred and forty OLTs were performed in adult 
recipients over the study period, using either the caval 
replacement technique or the piggyback technique, with 
or without a temporary porto-caval shunt. Veno-venous 
bypass was not used in any of these cases. Twenty 
patients underwent urgent transplantation, 3 received a 
combined liver-kidney transplant and 1 patient died intra-
operatively. These patients were excluded from further 
analysis. The remaining 116 patients were then grouped 
according to the absence or presence of post-operative 
AKI and compared with regards to demographics, 
aetiology, severity of liver disease and relevant co-
morbidity (Table 1). These groups were further compared 
in context of the donor graft and intraoperative chara-
cteristics (Tables 2 and 3 respectively).
Incidence of AKI
Out of the 116 patients included in the study, 58 (50%) 
developed early AKI post OLT using the AKIN criteria[22]. 
In those sustaining this post-operative complication, 
19 were classified as stage 1, 7 as stage 2 and 32 as 
stage 3 acute kidney injuries. Twenty-eight/116 (24%) 
patients required CVVHF during the post-operative 
admission on ICU. The indication for commencement of 
renal replacement therapy was AKI in all these cases. 
Ninety/116 (77.6%) patients had a baseline serum 
creatinine < 100 μmol/L and 26/116 (22.4%) had a base-
line serum creatinine > 100 μmol/L. The incidence of AKI 
post OLT was 48/90 (53%) in the former group, compared 
to 10/26 (38%) in the latter group, this difference not 
being statistically significant (χ 2 = 1.78, P = 0.182). 
However, a greater proportion of those with pre-existing 
renal impairment (baseline creatinine > 100 μmol/L) 
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developed stage 3 AKI (35% vs 26%) P = 0.081 and 
required CVVHF (35% vs 21%) P = 0.156 during the 
post-operative admission to ICU, compared to the group 
with a normal baseline creatinine although again this was 
not statistically significant.
AKI and clinical outcomes
The median time to extubation was 37 h in the group 
sustaining AKI compared to 16 h in those without AKI (P 
< 0.0001) (Figure 1). Additionally, median intensive care 
length of stay was 5 d in the AKI group compared to 2.5 
d in the no AKI group (P < 0.0001) (Figure 1). At the 6-mo 
follow-up period 39% of those with early post OLT AKI 
had developed CRF compared to 25% of those without 
AKI, although this did not reach statistical significance (P 
= 0.142). 
Risk factors for AKI
Variables associated with AKI on regression analysis 
are described in Table 4. On univariate analysis surgical 
technique, transfusion of red cell concentrate, fresh frozen 
plasma, platelets and cell salvage blood and peak AST 
within 24 h after OLT were all associated with an increased 
risk of the development of AKI. In a multivariate model 
that included all clinically relevant variables, only peak 
AST within the first 24 h post OLT remained statistically 
significant in predicting early AKI (P = 0.020). 
Incidence and severity and of HIRI
To assess the severity of HIRI, patients were divided into 
groups based on peak AST levels within the first 24 h after 
OLT: AST < 1000 IU/L (minor HIRI); AST 1000-5000 
IU/L (moderate HIRI); AST > 5000 IU/L (severe HIRI)[23]. 
Thirty-five/116 (30%) of patients developed mild HIRI, 
68/116 (59%) developed moderate HIRI and 13/116 
(11%) developed severe HIRI. The effect of organ status 
and surgical technique on HIRI severity and the renal 
implications of increasing ischaemia reperfusion injury 
are summarised in Table 5.
Correlation of renal dysfunction and HIRI
Median peak AST levels within the first 24 h post OLT 
were 1248 IU/L and 2059 IU/L in the No AKI and AKI 
groups respectively (P = 0.0003). Furthermore, increasing 
levels of peak AST correlated well with increasing severity 
of AKI (Spearman’s r = 0.334, P = 0.0003). Finally, 
increasing severity of HIRI was associated with both a 
higher incidence of AKI (P = 0.002) and more frequent 
use of CVVHF (P = 0.003) (Figure 2).
Correlation of organ status and HIRI
Median peak AST levels within the first post-operative 
day were 1307 IU/L and 2060 IU/L in those who 
underwent DBD and DCD transplantation respectively (P 
= 0.001). A spearman’s rank-order correlation was run 
to examine the relationship between organ status and 
HIRI, which revealed a positive correlation between the 
two (spearman’s r = 0.322, P = 0.0005). Five thirteenths 
(38.5%) of those with severe HIRI had received a DCD 
graft, compared to only 1/35 (3%) of those with mild 
HIRI, P = 0.007 (Table 5). 
HIRI and clinical outcomes
Increasing severity of HIRI was associated with a trend 
Variables No AKI 
(n  = 58)
Any grade of 
AKI (n  = 58)
P  value
Patient characteristics
Age (yr)   54 (18) 56 (6) 0.197
Female      17 (29%)       16 (28%) 0.837
Weight (kg)   75 (13)   79 (15) 0.163
Aetiology
Alcohol 13 14
Viral hepatitis 20 25
NASH   2   7
Autoimmune 16   7
Hepatocellular carcinoma 10 13
Other   7   6
MELD score 16 (7)      16 (5.75) 0.421
Hypertension        8 (14%)        9 (16%) 0.733
Diabetes mellitus      12 (21%)      20 (34%) 0.074
Pre-operative Haemoglobin (g/L) 114 (20) 107 (26) 0.072
Baseline creatinine   76 (39)   75 (26) 0.932
Table 1  Patient demographics
Values expressed as mean (SD), median (interquartile range) and number 
(percentage) where appropriate. AKI: Acute kidney injury; NASH: Non-
alcoholic steato-hepatitis; MELD: Model for End-Stage Liver Disease.
Variables No AKI 
(n  = 58)
Any AKI 
(n  = 58)
P  value
Graft characteristics
Donor age (yr) 50 (14) 47 (15) 0.219
Organ status
DCD (%)      7 (12%)    10 (17%) 0.454
Cold Ischaemic time (min) 493 (133) 493 (106) 0.502
Table 2  Donor graft characteristics
Values expressed as mean (SD), median (interquartile range) and number 
(percent) where appropriate. DCD: Donation after cardiac death; AKI: 
Acute kidney injury.
Variable No AKI 
(n  = 58)
Any AKI 
(n  = 58)
P  value
Intraoperative variables
Surgical technique
Piggyback    33 (57%)    22 (38%) 0.041
Intraoperative blood products
RCC transfusion (units) 1 (3) 4 (5) 0.001
FFP transfusion (units) 0 (2) 2 (6) 0.001
Platelet transfusion (units) 0 (1) 0 (2) 0.024
Cell salvage (mL) 281 (550) 764 (929) 0.001
Noradrenaline infusion rate on 
arrival to ICU (μg/kg per minute)
0.16 (0.10) 0.18 (0.13) 0.343
Table 3  Intraoperative variables
Values expressed as mean (SD), median (interquartile range) and number 
(percent) where appropriate. AKI: Acute kidney injury; RCC: Red cell 
concentrate; FFP: Fresh frozen plasma; ICU: Intensive care unit.
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towards longer median time to extubation (Figure 3) P 
= 0.07, longer median ICU length of stay (Figure 3) P = 
0.01, and a trend towards a higher incidence of CRF at 
6 mo (Table 5) P = 0.195.
The combined impact on clinical outcomes of AKI and 
HIRI
To examine the clinical impact of having both the com-
plications of AKI and HIRI, the cohort was divided into 4 
groups: Those with neither AKI nor HIRI (group 1); HIRI 
but no AKI (group 2); AKI but no HIRI (group 3) and 
those with both complications (group 4). The presence of 
HIRI included any patient that sustained either moderate 
or severe HIRI (peak AST within 24 h post OLT > 1000 
IU/L). These groups were then compared for median 
time to extubation, median ICU length of stay and the 
incidence of CRF. 
The median time to extubation (hours) differed between 
the groups (P < 0.001) with the lowest time observed 
in group 1 and the highest observed in group 4 (Figure 
4). Pairwise comparisons revealed statistically significant 
differences between groups 1 and 4 (P = 0.001) and 
groups 2 and 4 (P = 0.003). 
Similarly, the median ICU length of stay (days) in-
creased between the groups (P = 0.001), with the highest 
value observed in the patients sustaining both AKI and 
HIRI (Figure 4). Pairwise comparisons revealed stati-
stically significant differences between groups 1 and 3 
(P = 0.04), groups 1 and 4 (P < 0.0001) and groups 2 
and 4 (P = 0.005). Finally, there was a trend towards 
a higher incidence of CRF in those with any one of, or 
both AKI and HIRI compared to those with neither, with 
an incidence of only 15% in group 1 and 45% in group 
4 (P = 0.238). 
Survival
Kaplan Meier analysis revealed a reduction in 90-d patient 
survival associated with the presence of early AKI com-
pared to no AKI (91.4% vs 100% respectively, P = 
0.024) and increasing severity of HIRI (severe 84.6%; 
Univariate analysis Multivariate model
Variables Odds ratio (95%CI) P  value Odds ratio (95%CI) P  value
Male gender 1.088 (0.49-2.44) 0.837 0.430 (0.07-2.55) 0.352
Weight 1.020 (0.99-1.05) 0.164 1.026 (0.96-1.10) 0.455
Age   1.034 (0.999-1.07) 0.058 1.121 (1.02-1.23) 0.019
Pre-transplant
Diabetes mellitus 2.130 (0.92-4.92) 0.077   2.429 (0.48-12.41) 0.286
Hypertension 1.197 (0.43-3.36) 0.733 0.593 (0.04-8.04) 0.694
Serum creatinine 1.000 (0.99-1.01) 0.937   0.979 (0.96-1.002) 0.078
MELD 1.010 (0.97-1.05) 0.639 0.992 (0.91-1.08) 0.845
Haemoglobin   0.985 (0.97-1.002) 0.076 0.977 (0.93-1.02) 0.311
Graft characteristics
DCD organ 1.488 (0.52-4.23) 0.455   2.638 (0.30-23.12) 0.381
Donor age 0.984 (0.96-1.01) 0.218 0.964 (0.92-1.01) 0.160
Cold ischaemic time   1.001 (0.99-1.004) 0.498 1.000 (0.99-1.01) 0.984
Peak serum AST < 24 h post OLT   1.001 (1.00-1.001) 0.001   1.001 (1.00-1.001) 0.020
Perioperative course
Caval replacement surgical technique 2.160 (1.03-4.54) 0.042   3.289 (0.71-15-25) 0.128
Noradrenaline infusion rate on ICU arrival     4.830 (0.19-125.48) 0.343     47.468 (0.12-1836.27) 0.204
RCC transfusion 1.137 (1.03-1.26) 0.014 0.917 (0.64-1.32) 0.645
FFP transfusion 1.201 (1.07-1.35) 0.003 1.118 (0.84-1.48) 0.440
Platelet transfusion 1.499 (1.04-2.16) 0.030   1.948 (0.871-4.36) 0.104
Cell salvage volume   1.001 (1.00-1.001) 0.025       1.00 (0.999-1.002) 0.808
Table 4  Logistic regression analysis of variables associated with early acute kidney injury after liver transplantation
CI: Confidence interval; MELD: Model for End-Stage Liver Disease; DCD: Donation after Cardiac death; ICU: Intensive care unit; RCC: Red cell concentrate; 
FFP: Fresh frozen plasma; AST: Aspartate aminotransferase; OLT; Orthotopic liver transplantation.
Severity of HIRI
Mild (n  = 35) Moderate (n  = 68) Severe (n  = 13) P  value
DCD organs 1/35 (2.9) 11/68 (16.2)   5/13 (38.5) 0.007
Caval replacement 16/35 (45.7) 36/68 (52.9)   9/13 (69.2) 0.348
Incidence of AKI 12/35 (34.3) 34/68 (50.0) 12/13 (92.3) 0.002
Need for CVVHF   5/35 (14.3) 15/68 (22.1)   8/13 (61.5) 0.003
Development of CRF   6/30 (20.0) 19/53 (35.8)   5/11 (45.5) 0.195
Table 5  The effect of organ status and surgical technique on hepatic ischaemia reperfusion injury severity and the renal implications 
of increasing ischaemia reperfusion injury  n  (%)
HIRI: Hepatic ischaemia reperfusion injury; DCD: Donation after Cardiac death; AKI: Acute kidney injury; CVVHF: Continuous veno-venous 
haemofiltration; CRF: Chronic renal failure.
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moderate 95.5%; mild 100.0%, P = 0.053) (Figure 
5). Furthermore, early AKI and moderate/severe HIRI 
occurring in combination had a greater impact on 90-d 
patient survival than either complication when occurring in 
isolation (89% vs 100% respectively, P = 0.049) (Figure 6). 
DISCUSSION
This single centre study has allowed detailed analysis of 
factors influencing post-operative AKI in United Kingdom 
patients undergoing LT, allowing strategies for intervention 
to be designed. In particular it has investigated the impact 
of HIRI, which is becoming more prevalent in an era that 
has seen a steady rise in the use of marginal grafts. The 
aetiology of AKI following OLT is complex and multifactorial, 
so our study has benefitted from the analysis of details that 
are not collected in national databases. 
The importance of AKI and HIRI to the outcome 
of patients undergoing OLT is emphasised by major 
differences being demonstrated in this small single centre 
study in important patient centred outcomes. Patients 
who sustained both AKI and HIRI had a longer time to 
extubation, longer ICU length of stay and a lower 90-d 
patient survival. Furthermore, in a multivariate model 
of all clinically relevant variables, HIRI was shown to 
be the single most important factor predicting post-
operative AKI, suggesting that it plays a critical role in 
the pathogenesis of renal dysfunction after LT. 
The association between HIRI and AKI has previously 
been reported, with Leithead et al[16] demonstrating 
peak postoperative AST as the main predictor of renal 
dysfunction after DCD transplantation. Renal outcomes 
were examined for those undergoing DCD transplantation, 
but not specifically correlated with the degree of HIRI. 
Glanemann et al[23] examined the clinical implications 
of increasing severity of hepatic preservation injury, and 
found it to be associated with initial graft non-function and, 
as in the current study, to be correlated with an increased 
duration of post-operative ventilation and haemodialysis. 
However Glanemann et al[23] did not define the cohort 
that developed AKI. For the first time we have shown 
that the combination of early AKI and moderate to severe 
HIRI leads to worse post OLT outcomes than either 
complication alone. 
The aetiology of AKI following LT is thought to be 
multifactorial, and contributory causes include exposure 
to high levels of toxic free radicals, renal ischaemia, 
use of nephrotoxic medications and the effects of end 
stage liver disease on the kidneys. Perioperative risk 
factors for the development of AKI post OLT have 
included pre-existing renal dysfunction, diabetes mellitus, 
hypertension, previous ascites, MELD score, surgical 
technique, intraoperative transfusion of blood products, 
ischaemia time, post-reperfusion syndrome and post OLT 
immunosuppression[24-26]. In our study, peak serum AST 
within 24 h of OLT, surgical technique and transfusion of 
M
ed
ia
n 
tim
e 
to
 e
xt
ub
at
io
n 
(h
)
60
50
40
30
20
10
0
No AKI                          AKI
Presence of AKI
Error bars: 95%CI
M
ed
ia
n 
IC
U
 le
ng
th
 o
f 
st
ay
 (
d)
6
5
4
3
2
1
0
No AKI                          AKI
Presence of AKI
Error bars: 95%CI
Figure 1  Bar graphs demonstrating median time to extubation and 
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kidney injury. ICU: Intensive care unit; AKI: Acute kidney injury.
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blood products were all statistically significant in univariate 
analysis in being predictors of early AKI. However only 
peak serum AST within 24 h of OLT remained so in the 
multivariate model. 
Previously it has been shown that DCD transplantation 
is associated with post-operative renal dysfunction[16]. 
This would be expected as the use of DCD grafts is 
associated with increased warm ischaemia, incidence of 
poor and non function of the graft and patient and graft 
mortality[27]. In our study we were not able to reproduce 
these results. This perhaps was secondary to the fact 
that only 15% of our cohort received DCD grafts, or that 
to compensate for the use of DCD organs the donors 
may have been younger, had lower cold ischaemia times 
or were transplanted into younger, fitter patients. 
It has been reported that pre-operative renal dys-
function is an independent predictor of post-OLT AKI 
and the need for CVVHF[28,29]. However, in our study, 
pre-operative serum creatinine was not a predictor for 
early post-OLT AKI in logistic regression analysis. In 
fact, a greater proportion of those with a pre-operative 
creatinine < 100 μmol/L developed early AKI (53%) 
than those with a pre-operative creatinine > 100 μmol/L 
(38%). One possibility to explain this may have been 
that better quality grafts with a lower donor risk index 
were matched to the higher risk recipients. 
Interestingly though, in those with pre transplant 
CRF who did develop AKI it was likely to be severe (stage 
3 AKI) and require CVVHF suggesting a predisposition 
to an increased severity of the complication in the 
setting of pre-operative dysfunction. The difference in 
outcome of our logistic regression analysis may reflect 
the discrepancies in the definitions used to categorise 
AKI. For example, Cabezuelo et al[30] categorised post-
op AKI as an increase in pre-operative serum creatinine 
> 50% (compared to our definition of > 150%). In 
addition, their team defined pre-operative acute renal 
impairment as an increase in creatinine > 50% from 
baseline, compared to our pre-operative renal function 
being defined by the serum creatinine on the day of 
transplantation alone. 
The main limitation of this study lies in its retro-
spective nature and the inability to control for factors with 
inter-individual variability, such as the indications and 
timing in use of CVVHF, which remained reliant on the 
judgment of the clinician. Also, the variable definitions 
of AKI mean that interpretation of results needs to be 
considered in context of the methodologies used. 
The frequency of AKI has increased in recent years, 
and this increase has occurred in parallel with a marked 
increase in the use of high-risk grafts. In the United 
Kingdom 29% of donors are over 60 years of age, 
over 20% are DCD, and clinically obese donors have 
doubled in the last 10 years. It is known that grafts from 
these extended criteria donors are more prone to HIRI 
and poor outcome[31]. HIRI is often more severe when 
implanting steatotic organs, and it has been reported 
that the incidence of AKI is significantly higher in patients 
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Figure 3  Increasing severity of hepatic ischaemia reperfusion injury 
compared with median time to extubation and median intensive care unit 
length of stay. ICU: Intensive care unit; HIRI: Hepatic ischaemia reperfusion injury.
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receiving grafts from donors with a high BMI, although 
long term survival was not significantly different when 
corrected for other variables, such as diabetes[32]. The 
accelerated search in recent years for methods to expand 
the organ donor pool has lead to the increasing use of 
higher risk grafts. This trend in activity has important 
implications on the recipient population in terms of 
increased morbidity and mortality post OLT, however, 
as extended criteria donor grafts are usually allocated 
to patients with lower MELD scores, this may impact on 
increased hospital stay, complications and costs but not 
necessarily poorer graft or patient survival figures. 
The role of graft injury and HIRI injury in the patho-
genesis of AKI is being increasingly recognised[16,30]. It 
is one of the most important causes of organ dysfunction, 
and is a major determinant of successful LT. The deleterious 
effects are not limited to the liver, but are seen in other 
organs, including the lungs and kidney[33]. IRI can trigger 
a systemic inflammatory response and subsequent multi-
organ failure, the injury being characterised by intra-
vascular oxidative stress and functional impairment of 
the mitochondria[34,35]. Peak serum AST is a surrogate 
marker of the severity of HIRI, and is closely correlated 
with the development of AKI, as confirmed in this 
study. Low values of AST following transplantation are 
associated with superior outcomes[36], and a reduction 
in AST levels have been used as a primary end point for 
liver IRI studies in animal models. Preliminary results 
from a proof of concept study of normothermic machine 
perfusion compared to a standard cold preservation 
demonstrated a marked reduction in peak AST levels 
(417 IU/L vs 902 IU/L respectively), indicating that this 
method of preservation, by “reconditioning” the graft, may 
reduce HIRI and its attendant consequences, including 
AKI[37]. 
Conclusion
In summary, our study has shown that renal dysfunction 
and use of CVVHF after OLT is common, and rises in 
proportion to the level of hepatic-ischaemia-reperfusion-
injury (as determined by AST levels) and its coexisting 
systemic inflammatory response. Further work should 
focus on novel therapies that prevent and treat this graft-
related injury to improve recipient outcomes and broaden 
the donor pool with more extended criteria grafts. 
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higher risk grafts have on the recipient in LT. A few reports have addressed the 
association between HIRI and renal dysfunction post LT but none have explored 
the clinical impact of having both HIRI and AKI as a combined outcome. 
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In this study, the authors have shown for the first time that not only do early AKI 
and moderate to severe HIRI as individual complications, lead to poorer patient 
outcomes, but combined have a worse impact on time to extubation, intensive 
care unit length of stay and 90-d survival when compared to each complication 
alone. 
Applications
This study has highlighted the adverse extra-hepatic consequences of HIRI 
and the subsequent need to develop novel therapies that prevent and treat this 
graft-related injury to improve recipient outcomes and broaden the donor pool 
with more extended criteria grafts. 
Terminology
AKI: Acute kidney injury, as defined by the AKIN criteria (multiple rise in creatinine 
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reperfusion injury; A graft related injury causing a systemic inflammatory response 
that has, in this study been categorised according to peak serum aspartate 
aminotransferase levels on day one post LT.
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